Home
All Journals
Neuropsychiatric Disease and Treatment
List of Issues
Volume 17, Issue
Treatment Continuation of Asenapine or O ....

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Neuropsychiatric Disease and Treatment Volume 17, 2021 - Issue

Submit an article Journal homepage

Open access

217

Views

CrossRef citations to date

Altmetric

Original Research

Treatment Continuation of Asenapine or Olanzapine in Japanese Schizophrenia Patients: A Propensity Score Matched Study

Haruna Matsuzaki1 Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Masakazu Hatano1 Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan;2 Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, JapanCorrespondence[email protected]

https://orcid.org/0000-0001-7032-878X

Miko Iwata1 Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Shigeki Yamada1 Department of Clinical Pharmacy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

Pages 3655-3661 | Published online: 14 Dec 2021

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (3)

Shuhei Wada, Kunihiro Iwamoto, Hiroki Okumura, Hirotake Hida, Shuichi Hiraoka, Aya Kamei, Daisuke Mori, Kiyofumi Yamada & Norio Ozaki. (2023) Sensory evaluation of the bitterness of asenapine using D-sorbitol pretreatment: single-blind, placebo-controlled, crossover trial. BMC Psychiatry 23:1.
Crossref

. (2023) Asenapine/olanzapine. Reactions Weekly 1938:1, pages 233-233.
Crossref

Jolanta Orzelska-Górka, Joanna Mikulska, Anna Wiszniewska & Grażyna Biała. (2022) New Atypical Antipsychotics in the Treatment of Schizophrenia and Depression. International Journal of Molecular Sciences 23:18, pages 10624.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references